Evaluation of the Efficacy of a Novel Cardiovascular Rehabilitation Program on Improving Functional Capacity and Quality of Life in Patients with Coronary Artery Disease.

Project Abstract

Evaluation of the Efficacy of a Novel Cardiovascular Rehabilitation Program on Improving Functional Capacity and Quality of Life in Patients with Coronary Artery Disease This project aims to evaluate the efficacy of a novel cardiovascular rehabilitation program in improving functional capacity and quality of life in patients with coronary artery disease (CAD). Cardiovascular disease, including CAD, is a leading cause of morbidity and mortality worldwide, posing a significant public health challenge. Cardiac rehabilitation (CR) has been recognized as an essential component of comprehensive care for patients with CAD, as it has been shown to enhance functional capacity, reduce the risk of recurrent events, and improve overall quality of life. Despite the well-established benefits of traditional CR programs, there is a need for innovative approaches that can further optimize outcomes for patients with CAD. This project will investigate the effectiveness of a novel CR program that incorporates a comprehensive and personalized approach to address the multifaceted needs of this patient population. The study will be conducted as a randomized controlled trial, with participants randomly assigned to either the novel CR program or a control group receiving standard CR. The novel CR program will feature a tailored exercise regimen, personalized dietary counseling, and targeted psychological support, all of which will be designed to address the unique challenges and needs of each patient. The primary outcome measures will be changes in functional capacity, as assessed by a standardized exercise test, and improvements in quality of life, as measured by validated patient-reported outcome instruments. Secondary outcomes will include changes in cardiovascular risk factors, such as blood pressure, lipid profile, and body composition, as well as the incidence of adverse cardiovascular events during the study period. The study will enroll a diverse sample of patients with CAD, including those who have recently undergone revascularization procedures, such as percutaneous coronary intervention or coronary artery bypass grafting, as well as those with stable angina or a history of myocardial infarction. Participants will be followed for a period of 6 months, with assessments conducted at baseline, 3 months, and 6 months. The findings of this project will have important implications for the management of patients with CAD. If the novel CR program demonstrates superior outcomes compared to the standard CR approach, it could pave the way for the adoption of this innovative approach in clinical practice. This could lead to enhanced functional capacity, improved quality of life, and ultimately, better long-term outcomes for patients with CAD. Moreover, the insights gained from this study may inform the development of future CR programs and guide the optimization of existing ones. By exploring the impact of a personalized and comprehensive approach to CR, this project has the potential to contribute to the advancement of cardiovascular rehabilitation research and practice, ultimately benefiting the health and well-being of individuals living with CAD.

Project Overview